Apremilast FDA approved for Behcets in 2019 based on significant improvement in oral ulcer severity. What about genital ulcers? There was a signif improvement in QOL, but a nonsignificant trend to genital ulcer resolution (71% vs 41%) in 17 pts. https://t.co/OqDGcklyot